重症监护的成本效益:对经验评估的系统审查
Fotios Tatsis1, Mary Gouva2, Elena Dragioti2
1Intensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.
Healthcare (Basel, Switzerland)
|November 13, 2025
概括
成本效益分析 (CEA) 显示,重症监护室 (ICU) 的预防策略往往占主导地位. 药物治疗和生命支持疗法提供了不一致的价值,需要特定的环境经济评估以有效地分配资源.
科学领域:
- 卫生经济学 卫生经济学
- 关键护理医学 关键护理医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 重症监护室 (ICU) 是重要的,但资源密集的医疗保健领域.
- 随着需求和成本的上升,需要进行强有力的成本效益分析 (CEA),以便有效地分配资源.
- 对ICU干预措施的经济评估对于为政策和临床决策提供信息至关重要.
研究的目的:
- 系统地审查和综合ICU干预措施的经济评估.
- 进行元分析,以评估ICU干预的成本效益和价值.
- 为政策,临床决策和重症监护的未来研究提供信息.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 在成年ICU人群中包括基于试验的经济评估.
- 将成本标准化为2024美元,并使用增量净收益 (INB) 框架进行综合.
主要成果:
- 包括15个经济评估,评估各种ICU干预措施.
- 成本效益比率差异很大,预防和基于协议的策略往往占主导地位.
- 对八项研究的元分析得出了总计15123美元的INB.
结论:
- 在ICU干预的成本效益方面存在显著的变化.
- 在ICU的预防和质量改善策略经常在经济上占主导地位.
- 药物治疗和生命支持疗法显示不一致的经济价值,需要特定的环境评估.
更多相关视频
07:05Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
6.4K
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
9.2K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
293
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
293
